Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations

Human Immunology
Yufeng YaoLi Shi

Abstract

The endoplasmic reticulum aminopeptidases (ERAPs), ERAP1 and ERAP2, makes a role in shaping the HLA class I peptidome by trimming peptides to the optimal size in MHC-class I-mediated antigen presentation and educating the immune system to differentiate between self-derived and foreign antigens. Association studies have shown that genetic variations in ERAP1 and ERAP2 genes increase susceptibility to autoimmune diseases, infectious diseases, and cancers. Both ERAP1 and ERAP2 genes exhibit diverse polymorphisms in different populations, which may influence their susceptibly to the aforementioned diseases. In this article, we review the distribution of ERAP1 and ERAP2 gene polymorphisms in various populations; discuss the risk or protective influence of these gene polymorphisms in autoimmune diseases, infectious diseases, and cancers; and highlight how ERAP genetic variations can influence disease associations.

Citations

Nov 16, 2019·European Journal of Immunology·Kathrin Textoris-TaubeUlrike Seifert
Mar 19, 2020·Cells·Irma SaulleMara Biasin
Aug 15, 2020·Frontiers in Immunology·Fabiana PaladiniRosa Sorrentino
Aug 23, 2020·International Journal of Molecular Sciences·Ombretta MelaiuDoriana Fruci
Feb 6, 2020·Biological & Pharmaceutical Bulletin·Masafumi TsujimotoYoshikuni Goto
Feb 12, 2021·International Journal of Molecular Sciences·Silvia D'AmicoDoriana Fruci
Nov 3, 2021·Investigative Ophthalmology & Visual Science·Sahar GelfmanUNKNOWN Regeneron Genetics Center

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.